Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04789928
Status:
COMPLETED
Last Update Posted:
2024-06-05
First Post:
2021-01-04
Brief Title:
Conservative Treatment of Catheter - Related Injections With GentamicineEDTA
Sponsor:
Institut Pasteur
Organization:
Institut Pasteur
Study Overview
Official Title:
Gentamicine-EDTA a New Anti-biofilm Strategy for the Conservative Treatment of Catheter-related Infections
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CATH-GE
Brief Summary:
Catheter-related infections are frequent Treatment without catheter removal is difficult because of the presence of biofilm The association of gentamicin and EDTA is active in vitro and in vivo against biofilms formed by Gram positive and Gram negative bacteria
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None